Clinical Trial: Efficacy and Safety of Anthrax Vaccine, GC1109

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional



Official Title: A Single Blind, Randomized, Placebo Control, Phase I Study to Evaluate the Safety and Immunogenicity of the GC1109 Administered by the Intramuscular Route in Healthy Men

Brief Summary:

  1. BACKGROUND The newly developed anthrax vaccine GC1109 has been proven safe and effective in preclinical studies.

  2. OBJECTIVE

    - To evaluate the immunogenicity and safety of the anthrax vaccine GC1109 in healthy male volunteers.

  3. STUDY DESIGN

    • single-blinded
    • randomized
    • placebo controlled
    • phase 1 study